From retail auto sales contradicting robust wholesale numbers to 15th Finance Commission submitting report to President, here are the top headlines
Pfizer and its German partner BioNTech SE said they had so far found no serious safety concerns
Pfizer and the maker of the other leading U.S. vaccine candidate have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late Nov
The US Food and Drug Administration "and the Democrats didn't want to have me get a Vaccine WIN, prior to the election, so instead it came out five days later - As I've said all along!" Trump said
Tuereci and Sahin are a "dream team" in that they reconciled their visions with the constraints of reality
Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine
U.S. West Texas Intermediate (WTI) crude CLc1 futures dropped 81 cents, or 2%, to $39.48 a barrel
The Pfizer trial started less than four months ago, and how long the vaccine will confer protection and how many will benefit are almost complete unknowns for now
NEW YORK (Reuters) - The S&P 500 and the Dow rallied sharply but closed shy of their records on Monday as investors bet that a full economic reopening was finally in sight following the first positive data from a late-stage COVID-19 vaccine trial.
The vaccine is the first to be tested in the United States to generate late-stage data
Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar
Experts caution against hyping early results
Firms hit hardest by restrictions made most gains, with airlines trading 30% higher
Pfizer's vaccine is not necessarily great news for India
President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year
The companies said the vaccine was more than 90% effective and they have so far found no serious safety concerns, priming it for possible speedy regulatory approvals
The comments followed a statement earlier on Monday by vaccine developers Pfizer Inc and BioNTech, who said their experimental Covid-19 vaccine was more than 90% effective
He labeled as "great news" Pfizer Inc's announcement on Monday that its experimental Covid-19 vaccine was more than 90% effective
The European Medicines Agency (EMA) started a rolling review of data from trials on the vaccine in early October.
Pfizer and BioNTech SE are first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine